ARCHIVES

NCI Must Limit Grant Payments for Now, Until Congress Approves FY03 Budget

This article is from The Cancer Letter archive.

Vol. 28 No. 45 | December 6, 2002

Download PDF Visit The Full Archive

Related Articles

ORI Final Findings Of Scientific Misconduct

September 16, 1994

DePinho Seeks New Review of Incubator Proposal

June 1, 2012

Archival photos: Senator Ernest “Fritz” Hollings, namesake of MUSC Hollings Cancer Center

February 2, 2021

CMS Allows Medicare Payment for Eloxatin, But Says Review of New Agents Likely

May 23, 2003

DCPC Advisors Consider Asking DRG For Section On Prevention & Control

May 14, 1993

The NCI director and acting FDA commissioner called for faster approval of cancer drugs in speech to FDA staff.

October 21, 2005